EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 160 filers reported holding EPIZYME INC in Q2 2020. The put-call ratio across all filers is 0.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $398,000 | -74.8% | 270,917 | -80.3% | 0.00% | – |
Q1 2022 | $1,581,000 | -33.3% | 1,374,522 | +44.9% | 0.00% | – |
Q4 2021 | $2,372,000 | -50.5% | 948,546 | +1.3% | 0.00% | -100.0% |
Q3 2021 | $4,793,000 | -40.6% | 936,261 | -3.5% | 0.00% | 0.0% |
Q2 2021 | $8,064,000 | -3.0% | 970,351 | +1.7% | 0.00% | -50.0% |
Q1 2021 | $8,314,000 | -23.7% | 954,464 | -4.9% | 0.00% | 0.0% |
Q4 2020 | $10,896,000 | -14.1% | 1,003,372 | -5.6% | 0.00% | -33.3% |
Q3 2020 | $12,678,000 | -28.6% | 1,062,690 | -3.9% | 0.00% | -25.0% |
Q2 2020 | $17,754,000 | +18.8% | 1,105,450 | +14.7% | 0.00% | 0.0% |
Q1 2020 | $14,945,000 | -36.2% | 963,672 | +1.2% | 0.00% | -20.0% |
Q4 2019 | $23,419,000 | +131.6% | 951,952 | -2.9% | 0.01% | +150.0% |
Q3 2019 | $10,111,000 | +1.2% | 980,236 | +23.1% | 0.00% | 0.0% |
Q2 2019 | $9,992,000 | +8.6% | 796,239 | +7.2% | 0.00% | 0.0% |
Q1 2019 | $9,198,000 | +101.2% | 742,433 | +0.0% | 0.00% | +100.0% |
Q4 2018 | $4,572,000 | -35.7% | 742,389 | +10.6% | 0.00% | -50.0% |
Q3 2018 | $7,113,000 | -19.4% | 671,129 | +3.1% | 0.00% | 0.0% |
Q2 2018 | $8,823,000 | -14.4% | 651,179 | +12.1% | 0.00% | -33.3% |
Q1 2018 | $10,311,000 | +42.3% | 580,898 | +0.6% | 0.00% | +50.0% |
Q4 2017 | $7,246,000 | -26.4% | 577,360 | +11.7% | 0.00% | -33.3% |
Q3 2017 | $9,847,000 | +29.2% | 516,940 | +2.4% | 0.00% | +50.0% |
Q2 2017 | $7,622,000 | -11.9% | 504,770 | +0.0% | 0.00% | 0.0% |
Q1 2017 | $8,655,000 | +42.8% | 504,670 | +0.8% | 0.00% | 0.0% |
Q4 2016 | $6,061,000 | +36.0% | 500,898 | +10.6% | 0.00% | +100.0% |
Q3 2016 | $4,456,000 | -5.1% | 452,789 | -1.2% | 0.00% | -50.0% |
Q2 2016 | $4,693,000 | -16.9% | 458,311 | -1.6% | 0.00% | 0.0% |
Q1 2016 | $5,645,000 | +6.4% | 465,745 | +40.6% | 0.00% | 0.0% |
Q4 2015 | $5,306,000 | +27.4% | 331,214 | +2.3% | 0.00% | +100.0% |
Q3 2015 | $4,164,000 | -17.7% | 323,800 | +53.6% | 0.00% | -50.0% |
Q2 2015 | $5,060,000 | +86.3% | 210,815 | +45.7% | 0.00% | +100.0% |
Q1 2015 | $2,716,000 | +5.6% | 144,644 | +6.0% | 0.00% | 0.0% |
Q4 2014 | $2,573,000 | -33.8% | 136,398 | -4.9% | 0.00% | 0.0% |
Q3 2014 | $3,889,000 | +40.9% | 143,455 | +61.7% | 0.00% | 0.0% |
Q2 2014 | $2,761,000 | +45.8% | 88,704 | +6.7% | 0.00% | 0.0% |
Q1 2014 | $1,894,000 | +16.5% | 83,166 | +6.4% | 0.00% | 0.0% |
Q4 2013 | $1,626,000 | -46.8% | 78,177 | +2.3% | 0.00% | 0.0% |
Q3 2013 | $3,058,000 | +322.4% | 76,449 | +197.2% | 0.00% | – |
Q2 2013 | $724,000 | – | 25,725 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |